» Articles » PMID: 17088459

Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients with Heart Failure and a Preserved Ejection Fraction

Overview
Journal Circulation
Date 2006 Nov 8
PMID 17088459
Citations 260
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nearly half of patients with heart failure have a preserved ejection fraction (HFpEF). Symptoms of exercise intolerance and dyspnea are most often attributed to diastolic dysfunction; however, impaired systolic and/or arterial vasodilator reserve under stress could also play an important role.

Methods And Results: Patients with HFpEF (n=17) and control subjects without heart failure (n=19) generally matched for age, gender, hypertension, diabetes mellitus, obesity, and the presence of left ventricular hypertrophy underwent maximal-effort upright cycle ergometry with radionuclide ventriculography to determine rest and exercise cardiovascular function. Resting cardiovascular function was similar between the 2 groups. Both had limited exercise capacity, but this was more profoundly reduced in HFpEF patients (exercise duration 180+/-71 versus 455+/-184 seconds; peak oxygen consumption 9.0+/-3.4 versus 14.4+/-3.4 mL x kg(-1) x min(-1); both P<0.001). At matched low-level workload, HFpEF subjects displayed approximately 40% less of an increase in heart rate and cardiac output and less systemic vasodilation (all P<0.05) despite a similar rise in end-diastolic volume, stroke volume, and contractility. Heart rate recovery after exercise was also significantly delayed in HFpEF patients. Exercise capacity correlated with the change in cardiac output, heart rate, and vascular resistance but not end-diastolic volume or stroke volume. Lung blood volume and plasma norepinephrine levels rose similarly with exercise in both groups.

Conclusions: HFpEF patients have reduced chronotropic, vasodilator, and cardiac output reserve during exercise compared with matched subjects with hypertensive cardiac hypertrophy. These limitations cannot be ascribed to diastolic abnormalities per se and may provide novel therapeutic targets for interventions to improve exercise capacity in this disorder.

Citing Articles

Mechanisms of exercise intolerance in hear-t failure with preserved ejection fraction (HFpEF).

Pecchia B, Samuel R, Shah V, Newman E, Gibson G Heart Fail Rev. 2025; .

PMID: 40080287 DOI: 10.1007/s10741-025-10504-3.


Six-minute walk test reveals delayed oxygen uptake kinetics in ischemic cardiomyopathy.

Rocco I, Matos-Garcia B, Viceconte M, Bublitz C, Menezes-Rodrigues F, Tallo F Braz J Med Biol Res. 2025; 58:e14276.

PMID: 39907410 PMC: 11793151. DOI: 10.1590/1414-431X2024e14276.


Safety and tolerability of the M2 muscarinic acetylcholine receptor modulator BAY 2413555 in heart failure with reduced ejection fraction in the REMOTE-HF study.

Fudim M, Khan M, Linz D, Lindenfeld J, MacRae C, Kimmeskamp-Kirschbaum N Sci Rep. 2024; 14(1):31585.

PMID: 39738130 PMC: 11685975. DOI: 10.1038/s41598-024-77111-4.


Mitochondrial Reactive Oxygen Species Dysregulation in Heart Failure with Preserved Ejection Fraction: A Fraction of the Whole.

Martinez C, Zheng A, Xiao Q Antioxidants (Basel). 2024; 13(11).

PMID: 39594472 PMC: 11591317. DOI: 10.3390/antiox13111330.


Prognostic value of heart rate and oxygen pulse response in heart failure with left ventricular ejection fraction over 40.

Tashiro M, Goda A, Yanagisawa Y, Nakamaru R, Funabashi S, Takeuchi S Clin Res Cardiol. 2024; .

PMID: 39557668 DOI: 10.1007/s00392-024-02577-1.